cysteinylglycine (Cys-Gly)

RN given refers to (L)-isomer; RN for cpd without isomeric designation not in Chemlne 7/13/83
Also Known As:
Cys-Gly; cysteinyl-glycine
Networked: 60 relevant articles (0 outcomes, 5 trials/studies)

Bio-Agent Context: Research Results


1. Di Simplicio, Paolo: 4 articles (02/2014 - 07/2003)
2. Di Giuseppe, Danila: 4 articles (02/2014 - 07/2003)
3. Priora, Raffaella: 3 articles (02/2014 - 11/2004)
4. Frosali, Simona: 3 articles (02/2014 - 11/2004)
5. Parodi, Oberdan: 3 articles (12/2007 - 03/2007)
6. Campolo, Jonica: 3 articles (12/2007 - 03/2007)
7. Parolini, Marina: 3 articles (12/2007 - 03/2007)
8. Cighetti, Giuliana: 3 articles (12/2007 - 03/2007)
9. Müller, Thomas: 2 articles (06/2014 - 02/2011)
10. Muhlack, Siegfried: 2 articles (06/2014 - 02/2011)

Related Diseases

1. Neoplasms (Cancer)
2. Hyperhomocysteinemia
03/01/1994 - "We determined reduced, oxidized, and protein-bound homocysteine, cysteine, and cysteinylglycine in plasma from 13 patients with hyperhomocysteinemia (total homocysteine in the range 30.6-159.8 mumol/L) due to cobalamin deficiency. "
10/01/2013 - "In the presented work a variation of total aminothiols (cysteine, glutathione, cysteinylglycine and homocysteine) in blood plasma have been shown at modelling hyperhomocysteinemia by daily intraperitoneal (0.6 mkmol/g body weight) and subcutaneous (0.12 mkmol/g body weight) introduction of homocysteine. "
07/01/2003 - "To study the relationships between Hcy levels and variations in the redox state governed by thiols, plasma levels of Hcy, cysteine, glutathione, cysteinylglycine, and corresponding disulfides and protein-mixed disulfides were evaluated in subjects with moderate hyperhomocysteinemia represented by heart-transplant patients with (HTRF) and without (HT) renal failure, as well as patients with renal failure of different origin (RF), and compared with those of a control group (C) of normal subjects matched for age and sex. "
12/01/2007 - "One hundred subjects, with or without CV risk factors, were enrolled to evaluate plasma and erythrocyte redox status (GSH, homocysteine, cysteine, cysteinylglycine), antioxidant vitamins (alpha-tocopherol and ascorbate), malondialdehyde, a lipid peroxidation product, and the presence of the GCLC-129 C/T polymorphism; an experimental hyperhomocysteinemia after methionine-induced stimulation of transsulfuration pathway was performed in 91% of enrolled subjects. "
11/01/2004 - "We assayed the redox forms of cysteine (reduced [CSH], oxidized [CSSC], and bound to protein [CS-SP]), cysteinylglycine (CGSH; cysteinylgycine disulfide [CGSSGC] and cysteinylglycine-protein mixed disulfide [CGS-SP]), glutathione (GSH; glutathione disulfide [GSSG] and glutathione-protein mixed disulfide [GS-SP]), homocysteine (Hcy; homocystine [HcyS] and homocystine-protein mixed disulfides [bHcy]), and protein sulfhydryls in the plasma of healthy subjects (divided into 8 groups ranging in age from birth to 70 years) and patients with mild hyperhomocysteinemia associated with cardiovascular disease (heart-transplant patients) or vascular atherosclerosis, with or without renal failure. "
3. Renal Insufficiency (Renal Failure)
4. Hepatocellular Carcinoma (Hepatoma)
5. Periodontitis

Related Drugs and Biologics

1. Glutathione (Reduced Glutathione)
2. Cysteine (L-Cysteine)
3. cysteinylglycine (Cys-Gly)
4. Sulfhydryl Compounds (Thiols)
5. gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)
6. Transferases
7. Folic Acid (Vitamin M)
8. Disulfides
9. Caspase 3 (Caspase-3)
10. Protein S

Related Therapies and Procedures

1. Transplants (Transplant)
2. Microelectrodes
3. Renal Dialysis (Hemodialysis)